Lindman H, Åström G, Ahlgren J, Villman K, Blomqvist C, Nygren P, et al. Individually tailored toxicity-based 5-fluorouracil, epirubicin and cyclophosphamide (FEC) therapy of metastatic breast cancer. AO [Internet]. 2007 Jan. 1 [cited 2026 May 18];46(2):165-71. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/26235